Pharmacokinetics and Safety Study of YZJ-1139 in Subjects With Mild, Moderate and Normal Hepatic Impairment
Clinical trial NCT06671509 · COMPLETED
Trial details
- NCT number
- NCT06671509
- Sponsor
- Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-22
- Primary completion
- 2024-04-18
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.